{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T04:42:45Z","timestamp":1768192965114,"version":"3.49.0"},"reference-count":46,"publisher":"CSIRO Publishing","issue":"1","license":[{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1071\/journalslicense"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The HIV incidence among Chinese men who have sex with men (MSM) has still been high over the past decade. Despite HIV pre-exposure prophylaxis (PrEP) being an effective prevention strategy, few studies have examined PrEP uptake and adherence in China. This study examined PrEP initiation and adherence among Chinese MSM enrolled in a multi-site PrEP demonstration trial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Three-month data for this study were drawn from a PrEP demonstration project in Guangzhou and Wuhan, China. The project aimed to increase the engagement of MSM in China for HIV\/STI screening, HIV risk reduction, and PrEP initiation and adherence through the use of a mobile phone app and community engagement with crowdsourcing of messages and study images. Part of the intervention was the provision of tenofovir\/emtricitabine as PrEP through two types of modalities: (1) once-daily oral dose (Daily-PrEP), or (2) event-driven dose (i.e. the 2\u00a0+\u00a01\u00a0+\u00a01 approach, Event-Driven PrEP). The outcome of interest was PrEP adherence, defined as missing fewer than five pills in the past 30\u00a0days for Daily PrEP, and no missed doses for the Event-Driven PrEP regimen. Univariate and multivariate logistic regressions were conducted for data analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 927 individuals started PrEP, with follow-up data available for 650 people (70%) after 3\u00a0months. There were 593 men with a median age of 30 years (range\u00a021\u201361 years) in this study. Of those people, 341 reported taking Daily-PrEP, and 93% (317\/341) reported missing fewer than five pills in the past 30\u00a0days. Among 252 participants who reported taking the Event-Driven PrEP regimen, 61.5% (155\/252) reported full adherence. Daily-PrEP users were more likely to report good adherence than Event-Driven PrEP users (OR\u00a07.28, P\u00a0&amp;lt;\u00a00.0001, 95% CI: 4.28\u201312.39).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We observed a higher adherence to daily PrEP compared with Event-Driven PrEP among a sample of MSM in China. Further research is needed to examine long-term PrEP adherence among MSM in China.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1071\/sh25074","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T07:26:18Z","timestamp":1764746778000},"source":"Crossref","is-referenced-by-count":0,"title":["Daily PrEP and event-driven PrEP adherence for men who have sex with men in China"],"prefix":"10.1071","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9444-8919","authenticated-orcid":true,"given":"Fei","family":"Teng","sequence":"first","affiliation":[{"name":"ADepartment of Population Health Science, John D. Bower School of Population Health, University of Mississippi Medical Center, Jackson, MS, USA. Email: fionafayeteng@gmail.com, pauburns@gmail.com, michael.welsch21@gmail.com, bwalker5@umc.edu"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul A.","family":"Burns","sequence":"additional","affiliation":[{"name":"ADepartment of Population Health Science, John D. Bower School of Population Health, University of Mississippi Medical Center, Jackson, MS, USA. Email: fionafayeteng@gmail.com, pauburns@gmail.com, michael.welsch21@gmail.com, bwalker5@umc.edu"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Welsch","sequence":"additional","affiliation":[{"name":"ADepartment of Population Health Science, John D. Bower School of Population Health, University of Mississippi Medical Center, Jackson, MS, USA. Email: fionafayeteng@gmail.com, pauburns@gmail.com, michael.welsch21@gmail.com, bwalker5@umc.edu"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Walker","sequence":"additional","affiliation":[{"name":"ADepartment of Population Health Science, John D. Bower School of Population Health, University of Mississippi Medical Center, Jackson, MS, USA. Email: fionafayeteng@gmail.com, pauburns@gmail.com, michael.welsch21@gmail.com, bwalker5@umc.edu"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Liang","sequence":"additional","affiliation":[{"name":"BZhongnan Hospital of Wuhan University, Wuhan, China. Email: keliang@whu.edu.cn"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haojie","family":"Huang","sequence":"additional","affiliation":[{"name":"CWuhan Tongxing LGBT Center, Wuhan, China. Email: huanghaojie1992@hotmail.com"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7012-5986","authenticated-orcid":true,"given":"Zhuoheng","family":"Yin","sequence":"additional","affiliation":[{"name":"DUniversity of North Carolina Project-China, Guangzhou, China. Email: zhuoheng.yin@seshglobal.org"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linghua","family":"Li","sequence":"additional","affiliation":[{"name":"EGuangzhou Eighth People\u2019s Hospital, Guangzhou, China. Email: llheliza@126.com"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9388-1799","authenticated-orcid":true,"given":"Chunyan","family":"Li","sequence":"additional","affiliation":[{"name":"FTokyo College, The University of Tokyo, Tokyo, Japan. Email: li.chunyan@mail.u-tokyo.ac.jp"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renslow","family":"Sherer","sequence":"additional","affiliation":[{"name":"GSection of Infectious Diseases and Global Health, Department of Medicine, The University of Chicago Medicine, 5841 S. Maryland Avenue, Chicago, IL, 60637, USA. Email: rsherer@bsd.uchicago.edu, ahazra2@bsd.uchicago.edu, jlio@uchicago.edu"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aniruddha","family":"Hazra","sequence":"additional","affiliation":[{"name":"GSection of Infectious Diseases and Global Health, Department of Medicine, The University of Chicago Medicine, 5841 S. Maryland Avenue, Chicago, IL, 60637, USA. Email: rsherer@bsd.uchicago.edu, ahazra2@bsd.uchicago.edu, jlio@uchicago.edu"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Lio","sequence":"additional","affiliation":[{"name":"GSection of Infectious Diseases and Global Health, Department of Medicine, The University of Chicago Medicine, 5841 S. Maryland Avenue, Chicago, IL, 60637, USA. Email: rsherer@bsd.uchicago.edu, ahazra2@bsd.uchicago.edu, jlio@uchicago.edu"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danwen","family":"Qiu","sequence":"additional","affiliation":[{"name":"HGilead Sciences, Shanghai, China. Email: danwen.qiu@gilead.com"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2804-1181","authenticated-orcid":true,"given":"Joseph D.","family":"Tucker","sequence":"additional","affiliation":[{"name":"IInstitute of Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. Email: jdtucker@med.unc.edu"},{"name":"JDermatology Hospital of Southern Medical University, Guangzhou, China."},{"name":"KClinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9026-707X","authenticated-orcid":true,"given":"Weiming","family":"Tang","sequence":"additional","affiliation":[{"name":"IInstitute of Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. Email: jdtucker@med.unc.edu"},{"name":"JDermatology Hospital of Southern Medical University, Guangzhou, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"67","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"issue":"23","key":"2026011120563672900_R1","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1097\/CM9.0000000000001842","article-title":"Prevention and control of HIV\/AIDS in China: lessons from the past three decades.","volume":"134","author":"Xu","year":"2021","journal-title":"Chin Med J"},{"issue":"48","key":"2026011120563672900_R2","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.46234\/ccdcw2021.249","article-title":"Research progress in the epidemiology of HIV\/AIDS in China.","volume":"3","author":"He","year":"2021","journal-title":"China CDC Wkly"},{"issue":"22","key":"2026011120563672900_R3","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1001\/jama.2019.2591","article-title":"Preexposure prophylaxis for the prevention of HIV infection: evidence report and systematic review for the US Preventive Services Task Force.","volume":"321","author":"Chou","year":"2019","journal-title":"JAMA"},{"key":"2026011120563672900_R4","unstructured":"New York State Department of Health AIDS Institute. PrEP to Prevent HIV and Promote Sexual Health. New York: NYSDOH AIDS Institute; 2025. Available at https:\/\/www.hivguidelines.org\/guideline\/hiv-prep\/ [cited 17 December\u00a02025]"},{"issue":"1","key":"2026011120563672900_R5","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-022-14117-5","article-title":"Co-creation using crowdsourcing to promote PrEP adherence in China: study protocol for a stepped-wedge randomized controlled trial.","volume":"22","author":"Sha","year":"2022","journal-title":"BMC Public Health"},{"key":"2026011120563672900_R6","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-4692-x","article-title":"Prepared for PrEP: preferences for HIV pre-exposure prophylaxis among Chinese men who have sex with men in an online national survey.","volume":"19","author":"Huang","year":"2019","journal-title":"BMC Infect Dis"},{"key":"2026011120563672900_R7","unstructured":"World Health Organization. Pre-exposure prophylaxis (PrEP). World Health Organization; 2025. Available at https:\/\/www.who.int\/teams\/global-hiv-hepatitis-and-stis-programmes\/hiv\/prevention\/pre-exposure-prophylaxis [cited 26 December 2023]"},{"key":"2026011120563672900_R8","unstructured":"Gilead. China National Medical Products Administration approves Truvada\u00ae for HIV pre-exposure prophylaxis (PrEP); 2020. Available at https:\/\/www.gilead.com\/news\/news-details\/2020\/china-national-medical-products-administration-approves-truvada-for-hiv-pre-exposure-prophylaxis-prep [cited 20 May 2023]"},{"issue":"7","key":"2026011120563672900_R9","doi-asserted-by":"publisher","first-page":"e455","DOI":"10.1016\/S2352-3018(22)00138-2","article-title":"Expansion of PrEP and PEP services in China.","volume":"9","author":"Wang","year":"2022","journal-title":"Lancet HIV"},{"issue":"5","key":"2026011120563672900_R10","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1097\/QAD.0000000000001385","article-title":"Defining the HIV pre-exposure prophylaxis care continuum.","volume":"31","author":"Nunn","year":"2017","journal-title":"AIDS"},{"issue":"2","key":"2026011120563672900_R11","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.48782","article-title":"Association of HIV preexposure prophylaxis use with HIV incidence among men who have sex with men in China: a nonrandomized controlled trial.","volume":"5","author":"Wang","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"2","key":"2026011120563672900_R12","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.48794","article-title":"Implementation of HIV preexposure prophylaxis in diverse, real-world settings.","volume":"5","author":"Bhamidipati","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"5","key":"2026011120563672900_R13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-055899","article-title":"Community-engaged mHealth intervention to increase uptake of HIV pre-exposure prophylaxis (PrEP) among gay, bisexual and other men who have sex with men in China: study protocol for a pilot randomised controlled trial.","volume":"12","author":"Li","year":"2022","journal-title":"BMJ Open"},{"key":"2026011120563672900_R14","unstructured":"Government of Canada. Wages and benefits in China. Government of Canada; 2019. Available at https:\/\/www.tradecommissioner.gc.ca\/china-chine\/wages-salaires.aspx?lang=eng"},{"issue":"11","key":"2026011120563672900_R15","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1093\/cid\/cix1086","article-title":"Daily and nondaily oral preexposure prophylaxis in men and transgender women who have sex with men: the human immunodeficiency virus prevention trials network 067\/ADAPT study.","volume":"66","author":"Grant","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2026011120563672900_R16","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1007\/s10461-022-03785-4","article-title":"Identifying strategies for improving pre-exposure prophylaxis adherence: perspectives from a sample of highly adherent young men who have sex with men.","volume":"27","author":"Xavier Hall","year":"2023","journal-title":"AIDS Behav"},{"key":"2026011120563672900_R17","doi-asserted-by":"publisher","DOI":"10.1016\/j.lansea.2023.100217","article-title":"High PrEP uptake, adherence, persistence and effectiveness outcomes among young Thai men and transgender women who sell sex in Bangkok and Pattaya, Thailand: findings from the open-label combination HIV prevention effectiveness (COPE) study.","volume":"15","author":"Weir","year":"2023","journal-title":"Lancet Reg Health Southeast Asia"},{"key":"2026011120563672900_R18","doi-asserted-by":"publisher","DOI":"10.1186\/s12911-017-0470-0","article-title":"How the public uses social media wechat to obtain health information in cCina: a survey study.","volume":"17","author":"Zhang","year":"2017","journal-title":"BMC Med Inform Decis Mak"},{"issue":"4","key":"2026011120563672900_R19","first-page":"138","article-title":"Maximizing the benefits of HIV pre-exposure prophylaxis.","volume":"25","author":"Buchbinder","year":"2018","journal-title":"Top Antivir Med"},{"key":"2026011120563672900_R20","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.10550","article-title":"WeChat-based mHealth intention and preferences among people living with schizophrenia.","volume":"8","author":"Xiao","year":"2020","journal-title":"PeerJ"},{"key":"2026011120563672900_R21","unstructured":"World Health Organization (WHO). WHO global strategy on people-centred and integrated health services: interim report. WHO: Geneva; 2015."},{"issue":"11","key":"2026011120563672900_R22","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.1007\/s10461-018-2151-0","article-title":"The role of social relationships in PrEP uptake and use among transgender women and men who have sex with men.","volume":"22","author":"Mehrotra","year":"2018","journal-title":"AIDS Behav"},{"key":"2026011120563672900_R23","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1007\/s10461-016-1458-y","article-title":"Experiences with HPTN 067\/ADAPT study-provided open-label PrEP among women in Cape Town: facilitators and barriers within a mutuality framework.","volume":"21","author":"Amico","year":"2017","journal-title":"AIDS Behav"},{"issue":"8","key":"2026011120563672900_R24","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.22692","article-title":"Characterization of HIV preexposure prophylaxis use behaviors and HIV incidence among US adults in an integrated health care system.","volume":"4","author":"Hojilla","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"10","key":"2026011120563672900_R25","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-053634","article-title":"Willingness, preferred ways and potential barriers to use pre-exposure prophylaxis for HIV prevention among men who have sex with men in China.","volume":"11","author":"Yu","year":"2021","journal-title":"BMJ Open"},{"issue":"2","key":"2026011120563672900_R26","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1177\/09564624241297830","article-title":"HIV risk perception and PrEP uptake among black MSM in Mississippi.","volume":"36","author":"Teng","year":"2025","journal-title":"Int J STD AIDS"},{"key":"2026011120563672900_R27","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25667","article-title":"Preference for daily versus on-demand pre-exposure prophylaxis for HIV and correlates among men who have sex with men: the China Real-world Oral PrEP Demonstration study.","volume":"24","author":"Zhang","year":"2021","journal-title":"J Int AIDS Soc"},{"issue":"10","key":"2026011120563672900_R28","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1097\/QAD.0000000000002913","article-title":"Offering a choice of daily and event-driven preexposure prophylaxis for men who have sex with men in the Netherlands: a cost-effectiveness analysis.","volume":"35","author":"van Hoek","year":"2021","journal-title":"AIDS"},{"issue":"5","key":"2026011120563672900_R29","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.1016\/j.amepre.2021.04.036","article-title":"Pre-exposure prophylaxis uptake, adherence, and persistence: a narrative review of interventions in the U.S.","volume":"61","author":"Garrison","year":"2021","journal-title":"Am J Prev Med"},{"issue":"5","key":"2026011120563672900_R30","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25733","article-title":"Imperfect adherence in real life: a prevention-effective perspective on adherence to daily and event-driven HIV pre-exposure prophylaxis among men who have sex with men - a prospective cohort study in Taiwan.","volume":"24","author":"Wu","year":"2021","journal-title":"J Int AIDS Soc"},{"issue":"4","key":"2026011120563672900_R31","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1007\/s13178-022-00736-5","article-title":"Switching to non-daily pre-exposure prophylaxis among gay and bisexual men in Australia: implications for improving knowledge, safety, and uptake.","volume":"19","author":"Philpot","year":"2022","journal-title":"Sex Res Social Policy"},{"issue":"5","key":"2026011120563672900_R32","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1097\/QAI.0000000000001965","article-title":"Factors associated with sex-related pre-exposure prophylaxis adherence among men who have sex with men in New York City in HPTN 067.","volume":"80","author":"Mannheimer","year":"2019","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2026011120563672900_R33","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101776","article-title":"Estimating benefits of using on-demand oral prep by MSM: a comparative modeling study of the US and Thailand.","volume":"56","author":"Stansfield","year":"2022","journal-title":"EClinicalMedicine"},{"issue":"7","key":"2026011120563672900_R34","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(18)30098-7","article-title":"The growing threat of China\u2019s HIV epidemic.","volume":"3","author":"Zheng","year":"2018","journal-title":"Lancet Public Health"},{"issue":"1","key":"2026011120563672900_R35","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-018-3463-4","article-title":"A systematic review of adherence to oral pre-exposure prophylaxis for HIV - how can we improve uptake and adherence?","volume":"18","author":"Sidebottom","year":"2018","journal-title":"BMC Infect Dis"},{"key":"2026011120563672900_R36","unstructured":"PrEP Watch. A snapshot of PrEP scale-up, registration and resources for China. PrEP Watch; 2019. Available at www.prepwatch.org\/country\/china\/"},{"key":"2026011120563672900_R37","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ijid.2018.08.006","article-title":"Adherence to pre-exposure prophylaxis among men who have sex with men: a prospective cohort study.","volume":"75","author":"Qu","year":"2018","journal-title":"Int J Infect Dis"},{"issue":"1","key":"2026011120563672900_R38","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-020-08488-w","article-title":"Low willingness to pay for pre-exposure prophylaxis (PrEP) among men who have sex with men (MSM) in China.","volume":"20","author":"Cao","year":"2020","journal-title":"BMC Public Health"},{"issue":"7","key":"2026011120563672900_R39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0200560","article-title":"\u201cFree Testing and PrEP without Outing Myself to Parents:\u201d motivation to participate in oral and injectable PrEP clinical trials among adolescent men who have sex with men.","volume":"13","author":"Fisher","year":"2018","journal-title":"PLoS ONE"},{"issue":"5","key":"2026011120563672900_R40","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1007\/s12325-020-01295-0","article-title":"Barriers to the wider use of pre-exposure prophylaxis in the United States: a narrative review.","volume":"37","author":"Mayer","year":"2020","journal-title":"Adv Ther"},{"issue":"22","key":"2026011120563672900_R41","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1097\/CM9.0000000000003383","article-title":"Chinese guidelines for the diagnosis and treatment of human immunodeficiency virus infection\/acquired immunodeficiency syndrome (2024 edition).","volume":"137","author":"Acquired Immunodeficiency Syndrome Professional Group, Society of Infectious Diseases, Chinese Medical Association; Chinese Center for Disease Control and Prevention","year":"2024","journal-title":"Chin Med J"},{"issue":"23","key":"2026011120563672900_R42","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.1097\/CM9.0000000000001181","article-title":"Consensus statement on human immunodeficiency virus pre-exposure prophylaxis in China.","volume":"133","author":"Xu","year":"2020","journal-title":"Chin Med J"},{"issue":"10","key":"2026011120563672900_R43","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25407","article-title":"Daily and event-driven pre-exposure prophylaxis for men who have sex with men in Belgium: results of a prospective cohort measuring adherence, sexual behaviour and STI incidence.","volume":"22","author":"Vuylsteke","year":"2019","journal-title":"J Int AIDS Soc"},{"issue":"10","key":"2026011120563672900_R44","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25389","article-title":"Motives for choosing, switching and stopping daily or event-driven pre-exposure prophylaxis \u2013 a qualitative analysis.","volume":"22","author":"Zimmermann","year":"2019","journal-title":"J Int AIDS Soc"},{"issue":"23","key":"2026011120563672900_R45","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1056\/NEJMoa1506273","article-title":"On-Demand preexposure prophylaxis in men at high risk for HIV-1 infection.","volume":"373","author":"Molina","year":"2015","journal-title":"N Engl J Med"},{"key":"2026011120563672900_R46","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.2147\/RMHP.S295114","article-title":"Risk management on pre-exposure prophylaxis adherence of men who have sex with multiple men: a multicenter prospective cohort study.","volume":"14","author":"Liu","year":"2021","journal-title":"Risk Manag Healthc Policy"}],"container-title":["Sexual Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/connectsci.au\/sh\/article-pdf\/doi\/10.1071\/SH25074\/1837995\/sh25074.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/connectsci.au\/sh\/article-pdf\/doi\/10.1071\/SH25074\/1837995\/sh25074.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T01:56:45Z","timestamp":1768183005000},"score":1,"resource":{"primary":{"URL":"https:\/\/connectsci.au\/sh\/article\/23\/1\/SH25074\/267144\/Daily-PrEP-and-event-driven-PrEP-adherence-for-men"}},"subtitle":[],"editor":[{"given":"Phillip","family":"Keen","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2,5]]}},"URL":"https:\/\/doi.org\/10.1071\/sh25074","relation":{},"ISSN":["1448-5028","1449-8987"],"issn-type":[{"value":"1448-5028","type":"print"},{"value":"1449-8987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"article-number":"SH25074"}}